Emergency County Clinical Hospital Brasov

Brasov 500326

0 studies enrolling now · 3 studies all time

What they study most

B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion, Chronic Lymphocytic Leukemia

Studies at this site

• Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela ) — Completed
• Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia — Stopped early
• Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion — Stopped early